{"name":"Atriva Therapeutics GmbH","slug":"atriva-therapeutics-gmbh","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"ATR-002 MEK Inhibitor","genericName":"ATR-002 MEK Inhibitor","slug":"atr-002-mek-inhibitor","indication":"Non-small cell lung cancer","status":"phase_1"}]}],"pipeline":[{"name":"ATR-002 MEK Inhibitor","genericName":"ATR-002 MEK Inhibitor","slug":"atr-002-mek-inhibitor","phase":"phase_1","mechanism":"MEK inhibitor","indications":["Non-small cell lung cancer"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxNVDFRcGxJVlFHSUJlTkk0SER6NnZqRFFYU1pRT1RWM2M0TllPeUFTMDk2QUlnYVZPVDRZSExCUEl6X2xwSVdQUDJ0UlFYRHFsbkFwVlVkbFNjeEloZFJiVWRkbmhyVmRoODBobjc4cHF3NzY2bU9xMFlVU0NYR1pISG5BR0IzUQ?oc=5","date":"2021-11-26","type":"pipeline","source":"EU-Startups","summary":"43 Top Biopharma Startups and Companies in Germany - EU-Startups","headline":"43 Top Biopharma Startups and Companies in Germany - EU","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1lbGpnLXJtT1drT3RRQlRhc1NZNTVoNERCajBsaEdVaWJQMEtLQVR1Z1p3ZWdYOGp0bVgzMDRiaGhLVURnWHNsWVl6MlRQclpLS3BBaFY2Um5yY1pteEhR?oc=5","date":"2020-09-02","type":"pipeline","source":"Nature","summary":"Atriva Therapeutics: a quantum leap in antiviral respiratory therapies - Nature","headline":"Atriva Therapeutics: a quantum leap in antiviral respiratory therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxOTEFSOU5hSnlzUHRKSHNIbDZzS1hCSS1GREFuZkRaaHd5eFY4dW5FM2djbFY2dGdORjYwOVNVaTRxUzhrN2VQRzZVVHFncXU3b3BaOXN2TmZ5UmNGM20zS2lzTDY4TDNyaVlFZTM1SGpBUzhGYS1vdlpXYVVuU01kekxJeGFrbjljei1FeF9saW9iYnZnc3NTZWMzc2M2el9IMzM5WmVqNjlMSkczX01fM08zNWpDcnZrbk1CclM2YnhYS2V3ODVWVXI3UVd6MV96VnV0UWVCVVdXYmpmUDZEaEJjdGUxUjhNa29ibU1RRmZtWWROdHhVbXJOVEc?oc=5","date":"2020-05-28","type":"trial","source":"GlobeNewswire","summary":"Atriva Therapeutics to Develop ATR-002 for Treatment of Patients with COVID-19 in Phase II Study - GlobeNewswire","headline":"Atriva Therapeutics to Develop ATR-002 for Treatment of Patients with COVID-19 in Phase II Study","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}